The Miami CTSI supports the feasibility committe for the Miller School of Medicine research enterprise. The Research Feasibility Committee reviews industry-sponsored clinical research studies.

The purpose of this committee is to optimize the allocation of institutional resources and effort, reduce duplicative studies, and improve the overall performance of clinical research at the Miller School of Medicine.

For each study type, please review the steps to submitting a feasibility intake form.

Beginning September 1, 2022, all new industry-sponsored clinical research studies, will be reviewed for feasibility by the Miller School of Medicine (MSOM) Research Feasibility Committee (RFC) prior to IRB submission.

What do I need to do?

Study teams will be required to complete the Feasibility Intake Form for all new, industry-sponsored clinical research studies, prior to IRB submission and ORA contracting.

Who do I contact with questions?

If you have any questions, please feel free to contact the Research Feasibility Committee at [email protected].

How long will it take?

Take a look at our Review Committee process and timeline.

Additional Resources

• Oneness Research Solution – Allows clinical research teams to query de-duplicated and de-identified UHealth and JHS patient data and generate aggregate counts, enabling preparatory-for-research activities, cohort discovery, and other clinical research activities.
• Epic Slicer Dicer User Guide – A basic SlicerDicer training video and related slide deck are available in our webinar platform. First time users will need to register for an account with your University of Miami email address. Once registered, follow the link and click “Enroll me” to view the video and materials.

Committee Members